Target Name: DPF2
NCBI ID: G5977
Review Report on DPF2 Target / Biomarker Content of Review Report on DPF2 Target / Biomarker
DPF2
Other Name(s): Protein requiem | UBID4 | Zinc finger protein ubi-d4 | D4, Zinc and Double PHD Fingers Family 4 | REQ | DPF2 variant 1 | D4, zinc and double PHD fingers family 2 | Double PHD fingers 2 | apoptosis response zinc finger protein | Ubi-d4 | Zinc finger protein ubi-d4 (isoform 1) | CSS7 | requiem, apoptosis response zinc finger | double PHD fingers 2 | protein requiem | BAF45D | OTTHUMP00000231631 | OTTHUMP00000231633 | MGC10180 | REQU_HUMAN | SMARCG2 | Requiem, apoptosis response zinc finger | BRG1-associated factor 45D | Apoptosis response zinc finger protein | ubi-d4

DPF2: Key Regulator of DNA Damage Repair and Cell Growth

DPF2 (Protein Requiem) is a protein that is expressed in various tissues throughout the body, including the brain, heart, and kidneys. It is a key regulator of the DNA damage repair pathway, which is involved in ensuring that damaged DNA is repaired and degraded properly to prevent the development of cancer.

DPF2 is a protein that is known for its role in preventing DNA damage and repair. It is a key regulator of the DNA damage repair pathway, which is involved in ensuring that damaged DNA is repaired and degraded properly to prevent the development of cancer.

One of the key functions of DPF2 is its role in preventing DNA double-strand breaks, which are a common type of damage to DNA that can occur during the repair process. Double-strand breaks can occur due to a variety of factors, including exposure to radiation, chemicals, or other forms of stress.

DPF2 helps to ensure that these types of breaks are repaired by the body's immune system. It does this by helping to recruit a group of immune cells called T cells to the site of the double-strand break. Once there, T cells help to stimulate an immune response, which leads to the formation of a specialized immune cell called a T-cell memory clone. This cell is responsible for repairing the double-strand break and ensuring that the DNA is fully repaired.

In addition to its role in preventing DNA double-strand breaks, DPF2 is also involved in regulating the growth and division of cells. It helps to ensure that cells are able to divide and grow in a controlled and orderly manner, and it also helps to prevent the formation of cancerous mutations.

DPF2 is a protein that is known for its role in preventing DNA damage and repair. It is a key regulator of the DNA damage repair pathway, which is involved in ensuring that damaged DNA is repaired and degraded properly to prevent the development of cancer.

In conclusion, DPF2 is a protein that plays a critical role in ensuring that the body's cells are able to repair and divide properly. It is involved in preventing DNA double-strand breaks and in regulating the growth and division of cells. As a result, it is a potential drug target and a biomarker for a variety of diseases, including cancer.

Protein Name: Double PHD Fingers 2

Functions: Plays an active role in transcriptional regulation by binding modified histones H3 and H4 (PubMed:28533407, PubMed:27775714). Is a negative regulator of myeloid differentiation of hematopoietic progenitor cells (PubMed:28533407). Might also have a role in the development and maturation of lymphoid cells (By similarity). Involved in the regulation of non-canonical NF-kappa-B pathway (PubMed:20460684)

The "DPF2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about DPF2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

DPF3 | DPH1 | DPH2 | DPH3 | DPH3P1 | DPH5 | DPH5-DT | DPH6 | DPH6-DT | DPH7 | DPM1 | DPM2 | DPM3 | DPP10 | DPP10-AS1 | DPP3 | DPP3-DT | DPP4 | DPP6 | DPP7 | DPP8 | DPP9 | DPP9-AS1 | DPPA2 | DPPA2P3 | DPPA3 | DPPA3P1 | DPPA3P2 | DPPA4 | DPPA4P3 | DPPA5 | DPPA5P4 | DPRX | DPRXP2 | DPRXP4 | DPT | DPY19L1 | DPY19L1P1 | DPY19L2 | DPY19L2P1 | DPY19L2P2 | DPY19L2P3 | DPY19L2P4 | DPY19L3 | DPY19L3-DT | DPY19L4 | DPY30 | DPYD | DPYD-AS1 | DPYS | DPYSL2 | DPYSL3 | DPYSL4 | DPYSL5 | DQX1 | DR1 | DRAIC | DRAM1 | DRAM2 | DRAP1 | DRAXIN | DRB sensitivity-inducing factor complex | DRC1 | DRC3 | DRC7 | DRD1 | DRD2 | DRD3 | DRD4 | DRD5 | DRD5P1 | DRD5P2 | DRG1 | DRG2 | DRGX | DRICH1 | DROSHA | DRP2 | DSC1 | DSC2 | DSC3 | DSCAM | DSCAM-AS1 | DSCAML1 | DSCC1 | DSCR10 | DSCR4 | DSCR8 | DSCR9 | DSE | DSEL | DSEL-AS1 | DSG1 | DSG1-AS1 | DSG2 | DSG3 | DSG4 | DSN1 | DSP | DSP-AS1